GABRG2 rs2383207: What Your Genotype Means
The rs2383207 variant is a genetic marker located within the GABRG2 gene, which plays a critical role in brain signaling. Research has associated this variant with altered GABAergic activity and a potential susceptibility to various epilepsy phenotypes.
What each genotype means
Typical GABRG2 function
This genotype represents the most common form of the GABRG2 gene in the general population. It is associated with standard GABAergic signaling, which is essential for normal brain activity. There is no evidence suggesting this specific genotype contributes to the epilepsy or seizure phenotypes linked to rare, pathogenic GABRG2 mutations.
This is the most common genotype found across all major global populations.
Common variant carrier
Carrying one copy of this variant is common and generally considered part of normal human genetic diversity. While the GABRG2 gene is known to harbor rare, highly impactful mutations that can cause epilepsy or febrile seizures, this specific common variant is not typically classified as a primary cause of such conditions. If you have concerns about neurological health or seizure history, please discuss them with your clinician.
This genotype is frequently observed in the general population, though exact frequencies vary by ancestry.
Common variant carrier
This genotype is a common variation in the GABRG2 gene and is generally not associated with clinical disease. While rare, pathogenic mutations in GABRG2 are linked to a spectrum of epilepsy syndromes, this common variant does not carry the same clinical significance. You should consult with a healthcare provider if you have specific medical concerns regarding neurological symptoms.
This genotype is present in a significant portion of the population, with frequencies varying across different ancestral groups.
Understanding the rs2383207 Variant
The rs2383207 variant is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that influences the expression or function of the GABRG2 gene. While many SNPs are neutral and have no observable effect on health, researchers study variants like rs2383207 to determine if they correlate with specific biological traits or disease risks. Because this variant is common in the general population, it is frequently included in large-scale genome-wide association studies (GWAS) aimed at mapping the genetic architecture of neurological conditions. Understanding its location helps scientists investigate how subtle changes in DNA sequence might influence the complex electrical activity of the human brain.
The Role of the GABRG2 Gene
The GABRG2 gene provides instructions for creating the gamma-2 subunit of the GABAA receptor. These receptors are essential components of the central nervous system, acting as the primary inhibitory neurotransmitter system in the brain. When GABA binds to these receptors, it helps dampen neuronal excitability, effectively acting as a 'brake' on brain activity to prevent over-stimulation. Because GABRG2 is vital for the proper assembly and function of these receptors, any disruption—whether through rare, highly penetrant mutations or common variants—can potentially alter the balance between excitation and inhibition in the brain. This balance is crucial for maintaining normal neurological function, and shifts in this equilibrium are often studied in the context of seizure disorders and other neurodevelopmental conditions.
Research and Evidence Strength
Current research into GABRG2 has established it as a significant gene in the study of epilepsy. While rare, highly disruptive mutations in GABRG2 are well-documented causes of specific epilepsy syndromes, the evidence for common variants like rs2383207 is considered moderate. Large-scale meta-analyses have identified signals in the GABRG2 region associated with various epilepsy phenotypes, suggesting that common genetic variation may contribute to an individual's overall susceptibility. However, it is important to note that the presence of this variant does not guarantee the development of any condition. Epilepsy is a complex, polygenic trait, meaning it is influenced by the interplay of many different genes, environmental factors, and developmental history. The association between rs2383207 and epilepsy is statistical, reflecting trends across large populations rather than individual clinical outcomes.
Population Frequency and Interpretation
The rs2383207 variant is classified as a common variant, meaning it is found at relatively high frequencies across diverse human populations. Because it is common, most people carry at least one copy of the variant allele. When interpreting genetic data, it is essential to distinguish between common variants that may slightly modulate risk and rare, pathogenic mutations that have a direct, high-impact effect on protein function. For a reader, this information is for educational purposes only. It cannot be used to diagnose a medical condition or predict personal health outcomes. If you have concerns about epilepsy, seizure history, or neurological health, the most appropriate step is to consult with a neurologist or a genetic counselor. They can provide context based on your personal and family medical history, which is far more predictive than any single genetic marker.
How common is this variant?
The rs2383207 variant is common across global populations, with the specific frequency of the A and G alleles varying by ancestry. It is widely distributed and present in most major ethnic groups.
Frequently asked questions
Does having the rs2383207 variant mean I will develop epilepsy?
No. This variant is a common genetic marker associated with a statistical increase in susceptibility in some studies, but it is not a direct cause of epilepsy. Most people with this variant do not develop epilepsy, as the condition is influenced by many genetic and environmental factors.
Can I use this information to change my medication?
Absolutely not. You should never change or stop any medication based on genetic information without consulting your doctor or pharmacist. Genetic variants can sometimes influence drug response, but clinical decisions must be made by a healthcare professional.
Where can I find more information about GABRG2?
You can find reliable information on the GABRG2 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene function and known clinical associations.
Is this variant considered a 'mutation'?
In genetics, the term 'variant' is preferred for common differences in DNA sequence like rs2383207. 'Mutation' is typically reserved for rare, highly disruptive changes that have a clear, direct impact on protein function and health.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2383207?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.